Elaine Blais, an esteemed leader at the law firm Goodwin Procter LLP, has proven herself as a strong force in the legal field once again. Her recent influential roles in significant patent disputes have caught the attention of the legal community. Notably, she helped Teva Pharmaceuticals triumph in an eventually reversed verdict in a complex patent lawsuit against Eli Lilly & Co. This case was centered on a patented migraine medication.
In addition to the Teva case, Blais also secured a victory for the industrial titan, General Electric, in a contentious disagreement over light bulbs. These notable achievements have affirmed her position amongst Law360’s 2023 Intellectual Property MVPs.
For those interested in delving deeper into attaining insights on how Elaine Blais’ legal acumen has helped shape the landscape of patent law, you can read the detailed account here.